Paxil class action
Executive Summary
Plaintiffs claiming Paxil is habit-forming will resubmit motion for class action certification after Los Angeles district court denied certification request Jan. 10, citing viability concerns for multi-state action. The court earlier denied the plaintiff's request to enjoin GSK from airing ads with "Paxil is non-habit forming" claim (1"The Pink Sheet" Aug. 26, 2002, p. 21)...
You may also be interested in...
Paxil TV Ad Case Could Produce Ruling On FDA’s Authority To Regulate Ads
A suit regarding claims in Paxil TV ads could produce a court ruling regarding FDA's authority to regulate advertising
QUOTED. 2 March 2021. Michael Coyle.
Representatives from cardiac monitoring device manufacturers and professional societies are working together to persuade Medicare carrier Novitas to reconsider its payment rates for extended cardiac monitoring. See what Michael Coyle, iRhythm’s CEO, said about it here.
Medicare Drug Pricing Demonstration Agenda May Be Reshaped By Fowler As CMMI Head
Elizabeth Fowler brings combination of Capitol Hill, White House and pharma industry experience to the role of director of the Center for Medicare and Medicaid Innovation.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: